Get started
Author

Parin Salim Sidat

Observed names: Parin S. Sidat, Parin Sidat, Parin ​ Sidat
ORCID: 0000-0002-0583-8991
Observed ORCID: 0000-0002-0583-8991
OpenAlex ID: A5030583440
Anticancer Biological Profile of Some Heterocylic Moieties-Thiadiazole, Benzimidazole, Quinazoline, and Pyrimidine
2022 · Parin Salim Sidat, Tasneem Mohamadbin Kasim Jaber, et al. · Pharmacophore · 21
Neem (Azadirachta indica): A Panacea of all Diseases
2023 · Parin ​ Sidat, Sakshi Modh, et al. · Journal of Pharmaceutical Research · 5
PDF
Design, synthesis and evaluation of novel coumarin-oxa/thiadiazole hybrids as AChE inhibitors for the treatment of alzheimer's disease
2024 · Tasneem Jaber, Uttam A More, et al. · Indian Journal of Chemical Technology · 4
Ethnomedicinal Plants Used for Treatment of Urolithiasis in India: A Review
2022 · Vishal Gokul Beldar, Parin Salim Sidat, et al. · Current Traditional Medicine · 4
Synthesis, DFT Studies, and Biological Evaluation of New Quinazoline-1,3,4-Thiadiazole Derivatives as Anti-proliferative Agents
2024 · Parin S. Sidat, Malleshappa N. Noolvi, et al. · Chemistry Africa · 2
WITHDRAWN: Exploration of Virtually Designed and Developed Thiadiazole Derivatives as ULK1/2 Inhibitors: In silico Approach
2023 · Malleshappa N Noolvi, Parin Salim Sidat, et al. · Letters in Drug Design & Discovery
ULK1/2 Inhibitor: Essential Component of Autophagic Cell Death Machinery
2022 · Parin Sidat, Malleshappa Noolvi, et al. · Journal of Pharmaceutical Research
PDF
Biological Anticancer Activity of Heterocyclic Compounds: Thiadiazole, Benzimidazole, Quinazoline, and Pyrimidine
2022 · Parin Salim Sidat, Tasneem Mohamadbin Kasim Jaber, et al. · Archive of International Journal of Cancer and Allied Science
PDF
Works count: 8
Citation count: 36
H-index: 4
I10-index: 1
Year
Topic
Type